These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 15758474)
41. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures. Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324 [TBL] [Abstract][Full Text] [Related]
42. Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Fujino H; Salvi S; Regan JW Mol Pharmacol; 2005 Jul; 68(1):251-9. PubMed ID: 15855407 [TBL] [Abstract][Full Text] [Related]
43. Prostaglandins enhance epidermal growth factor-induced DNA synthesis in hepatocytes by stimulation of E prostanoid 3 and F prostanoid receptors. Meisdalen K; Dajani OF; Christoffersen T; Sandnes D J Pharmacol Exp Ther; 2007 Sep; 322(3):1044-50. PubMed ID: 17567965 [TBL] [Abstract][Full Text] [Related]
44. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone. Lerner UH J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892 [TBL] [Abstract][Full Text] [Related]
45. [Effect of anabolic steroids on osteoporosis]. Adachi M; Takayanagi R Clin Calcium; 2008 Oct; 18(10):1451-9. PubMed ID: 18830042 [TBL] [Abstract][Full Text] [Related]
46. Prostaglandins in the kidney: developments since Y2K. Nasrallah R; Clark J; Hébert RL Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567 [TBL] [Abstract][Full Text] [Related]
47. Mechanisms involved in skeletal anabolic therapies. Martin TJ; Quinn JM; Gillespie MT; Ng KW; Karsdal MA; Sims NA Ann N Y Acad Sci; 2006 Apr; 1068():458-70. PubMed ID: 16831943 [TBL] [Abstract][Full Text] [Related]
48. The benefit of combining non-mechanical agents with mechanical loading: a perspective based on the Utah Paradigm of Skeletal Physiology. Jee WS; Tian XY J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):110-8. PubMed ID: 15951626 [TBL] [Abstract][Full Text] [Related]
49. Relaxin-3, INSL5, and their receptors. Liu C; Lovenberg TW Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022 [TBL] [Abstract][Full Text] [Related]
53. [Current topics in the regulation of prostanoids--3. Prostanoid synthases and prostanoid receptors]. Ohara M; Sawa T Masui; 1999 Jan; 48(1):42-7. PubMed ID: 10036888 [TBL] [Abstract][Full Text] [Related]